ECPI - MARK (IT)Aug 13, 20201 min readTribute video to all of the FrontlinersWe in E*Chi'mes Pharmaceutical Inc will never forget all of your hardwork during this crisis. We are here to help and support you all.
We in E*Chi'mes Pharmaceutical Inc will never forget all of your hardwork during this crisis. We are here to help and support you all.
NeuroAiD(TM)II holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic...SINGAPORE, Jan. 12, 2022 /PRNewswire/ -- Moleac is pleased to announce the release of the ATHENE study results, published in the Journal of the American Medical Director Association (JAMDA)1. Alzheime